HK1210163A1 - Compositions and methods for treating or preventing pneumovirus infection and associated diseases - Google Patents

Compositions and methods for treating or preventing pneumovirus infection and associated diseases Download PDF

Info

Publication number
HK1210163A1
HK1210163A1 HK15110967.1A HK15110967A HK1210163A1 HK 1210163 A1 HK1210163 A1 HK 1210163A1 HK 15110967 A HK15110967 A HK 15110967A HK 1210163 A1 HK1210163 A1 HK 1210163A1
Authority
HK
Hong Kong
Prior art keywords
methods
compositions
treating
associated diseases
pneumovirus infection
Prior art date
Application number
HK15110967.1A
Other languages
English (en)
Chinese (zh)
Inventor
Robert O. Cook
Eugene R. REYNOLDS
Boris Shekunov
Siead I. Zegar
Original Assignee
Microdose Therapeutx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Therapeutx, Inc. filed Critical Microdose Therapeutx, Inc.
Publication of HK1210163A1 publication Critical patent/HK1210163A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15110967.1A 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases HK1210163A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261666258P 2012-06-29 2012-06-29
US61/666,258 2012-06-29
PCT/US2013/048723 WO2014005098A2 (en) 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Publications (1)

Publication Number Publication Date
HK1210163A1 true HK1210163A1 (en) 2016-04-15

Family

ID=49778754

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15110967.1A HK1210163A1 (en) 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases
HK15104634.7A HK1203956A1 (en) 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15104634.7A HK1203956A1 (en) 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Country Status (17)

Country Link
US (2) US9040569B2 (enExample)
EP (1) EP2867216A4 (enExample)
JP (1) JP2015524391A (enExample)
KR (1) KR20150037946A (enExample)
CN (1) CN104507918A (enExample)
AU (1) AU2013282286A1 (enExample)
BR (1) BR112014032290A2 (enExample)
CA (1) CA2877941A1 (enExample)
EA (1) EA201590124A1 (enExample)
HK (2) HK1210163A1 (enExample)
IL (1) IL236476A0 (enExample)
IN (1) IN2014DN10680A (enExample)
MX (1) MX2014015340A (enExample)
NZ (1) NZ628880A (enExample)
TW (1) TWI516283B (enExample)
WO (1) WO2014005098A2 (enExample)
ZA (1) ZA201409073B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015524391A (ja) 2012-06-29 2015-08-24 マイクロドース セラピューテクス，インコーポレイテッド ニューモウイルス感染症および感染疾患を治療あるいは予防するための組成物および方法
US10258620B2 (en) * 2014-12-18 2019-04-16 Metriopharm Ag Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form
US20170151173A1 (en) * 2015-11-30 2017-06-01 Otic Pharma Inc. Compositions and methods for otologic prophylaxis and treatment
WO2018071443A1 (en) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
US20200085741A1 (en) * 2018-09-14 2020-03-19 Pharmosa Biopharm Inc. Pharmaceutical composition for controlled release of weak acid drugs and uses thereof
CN109827875A (zh) * 2019-04-10 2019-05-31 上海市食品药品检验所 一种用于测定吸入制剂溶出度的装置和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495580B1 (en) * 1998-01-29 2002-12-17 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EP1051169A4 (en) * 1998-01-29 2002-05-29 Viropharma Inc COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRAL INFECTIONS AND RELATED DISEASES
WO2002059132A1 (en) 2001-01-26 2002-08-01 Viropharma Incorporated Intermediate compounds useful for making antiviral compounds
CA2495245A1 (en) 2002-08-09 2004-02-19 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
CA2495266A1 (en) 2002-08-09 2004-02-19 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
JP2015524391A (ja) 2012-06-29 2015-08-24 マイクロドース セラピューテクス，インコーポレイテッド ニューモウイルス感染症および感染疾患を治療あるいは予防するための組成物および方法

Also Published As

Publication number Publication date
EA201590124A1 (ru) 2015-06-30
HK1203956A1 (en) 2015-11-06
MX2014015340A (es) 2015-03-05
JP2015524391A (ja) 2015-08-24
US9040569B2 (en) 2015-05-26
CN104507918A (zh) 2015-04-08
AU2013282286A1 (en) 2015-01-22
IN2014DN10680A (enExample) 2015-08-28
IL236476A0 (en) 2015-02-26
TW201416093A (zh) 2014-05-01
KR20150037946A (ko) 2015-04-08
EP2867216A4 (en) 2015-12-09
US20150209328A1 (en) 2015-07-30
TWI516283B (zh) 2016-01-11
US20140005239A1 (en) 2014-01-02
US9504672B2 (en) 2016-11-29
EP2867216A2 (en) 2015-05-06
NZ628880A (en) 2016-08-26
WO2014005098A2 (en) 2014-01-03
BR112014032290A2 (pt) 2017-06-27
WO2014005098A3 (en) 2014-02-27
CA2877941A1 (en) 2014-01-03
ZA201409073B (en) 2016-08-31

Similar Documents

Publication Publication Date Title
HK1207306A1 (en) Modified polynucleotides for the production of proteins associated with human disease
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
HK1203513A1 (en) Methods of preparing substituted nucleotide analogs
WO2013151666A3 (en) Modified polynucleotides for the production of biologics and proteins associated with human disease
IN2014DN09173A (enExample)
EA201491028A8 (ru) Способ получения замещенных 5-фтор-1н-пиразолопиридинов
CA2818938A1 (en) Compounds for treating respiratory syncytial virus infections
WO2014155300A3 (en) Substitued pyrimidine amine derivatives as tak-1 inhibitors
WO2014005098A3 (en) Compositions and methods for treating or preventing pneumovirus infection and associated diseases
WO2014072961A3 (en) Polymorphic forms of suvoroxant
WO2010139979A3 (en) Processes for preparing crystalline forms of dasatinib
EP2738153A4 (en) PROCESS FOR PREPARING 3,3-DIMETHYL-BUTYRALDEHYDE
WO2013014665A8 (en) Intermediate compounds and process for the preparation of lurasidone and salts thereof
EP2601967A4 (en) MEDICINE FOR PREVENTING AND TREATING HIV-RELATED OR HIV-RELATED DISEASES, INCLUDING AIDS
WO2013128379A3 (en) Crystalline polymorphic forms of linagliptin
TW201129572A (en) Compounds for treating respiratory syncytial virus infections
WO2010079045A3 (en) Crystalline salt forms of flibanserine
BR112013006857A2 (pt) composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica e método para o tratamento ou profilaxia de doenças virais
EP2634182A4 (en) PROCESS FOR THE PREPARATION OF 1,3,5-TRIOXANE
EP2634183A4 (en) PROCESS FOR THE PREPARATION OF 1,3,5-TRIOXANE
WO2010122575A3 (en) Process for the preparation of pure paliperidone
HK1202868A1 (en) Carboxamide-substituted heteroaryl-pyrazoles and the use thereof
UA104102C2 (en) α-CRYSTALLINE FORM OF CARBABENZPYRIDE
WO2009087151A9 (en) Polymorphic forms of moxifloxacin hydrochloride and processes for preparation thereof
WO2014102820A3 (en) Rivaroxaban intermediate and preparation thereof